Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of NHS England providing formal agreements in principle to pharmaceutical companies that commercial flexibility may be granted for multi-indication medicines (a) prior to and (b) pending the outcome of NICE evaluations.

I refer the Hon. Member to the answers my Rt Hon. Friend, the Minister of State for Health gave on 1 September 2025 to Questions 69240, 69241, and 69242.